Ultragenyx Pharmaceutical Inc. (RARE) Operating income 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) annual operating income history from SEC filings — each fiscal year as reported.
-$535.0MFY2025 · since FY2016: -$248.0M → -$535.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$535.0M | +0.2% |
| FY2024 | -$536.0M | +5.8% |
| FY2023 | -$569.0M | +12.3% |
| FY2022 | -$648.9M | -70.0% |
| FY2021 | -$381.7M | -15.6% |
| FY2020 | -$330.1M | +22.2% |
| FY2019 | -$424.2M | -14.2% |
| FY2018 | -$371.4M | -12.9% |
| FY2017 | -$328.9M | -32.6% |
| FY2016 | -$248.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice